Urban Children with Type 1 Diabetes Skyrockets
Over the past 20-years, the incidence of type 1 diabetes in children under age 5 has increased by 70 percent in the city of Philadelphia. These young children are at the highest risk for death.
New Nanotechnology can be Used for Type 1 Diabetes, Asthma, and Food Allergies
New nanotechnology can be applied to a variety of immune-mediated diseases including Type 1 diabetes, food allergies and airway allergies such as asthma.
Recovering T Regulatory Cells in Pancreas May Restore Insulin Production in Diabetics
The key to restoring production of insulin in type I diabetic patients, previously known as juvenile diabetes, may be in recovering the population of protective cells known T regulatory cells in the lymph nodes at the "gates" of the pancreas.
Type 1 Diabetes Rapidly Reversed Using Antibody Injections
Scientists have used injections of antibodies to rapidly reverse the onset of Type I diabetes.
New Cause of Cardiac Damage After Heart Attack in Type 1 Diabetics Found
After people with type 1 diabetes have a heart attack, their long-term chance of suffering even more heart damage skyrockets. Now researchers have identified the misstep that sparks this runaway chronic damage and a promising way to block it.
Target Identified for New Diabetes Drug
New research points to the naturally produced protein apolipoprotein A-IV as a potential target for a new diabetes therapeutic.
Study: Some Insulin Production in Long-Term Type 1 Diabetics
Research has shown that insulin production may persist for decades after the onset of type 1 diabetes.
Study Identifies Cause of Diabetes Misdiagnosis Among Asian Americans
Researchers have determined key differences between Type 1 and Type 2 diabetes in the Asian American population.
Researchers Provide World’s First View of Type 1 Diabetes as it Develops
Researchers have created the first cellular movies showing the destruction underlying type 1 diabetes in real-time in models.
New Target for Diabetes Treatment Discovered
Researchers have identified a key molecular pathway responsible for the natural decrease in the proliferation of insulin-producing cells that occurs as a person ages. Artificially activating this pathway, which is normally not functional in adults, may be a new way to combat diabetes.
Continuous Glucose Monitoring Helpful in Maintaining Target Blood Sugar Levels
The Endocrine Society released a clinical practice guideline (CPG) providing recommendations on settings where patients are most likely to benefit from continuous glucose monitoring (CGM).
Uterine Stem Cells Used to Treat Diabetes
Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published in the journal Molecular Therapy.
Breakthrough Discovery Points Way Toward Diabetes Cure
Researchers have identified the key signal that prompts production of insulin-producing beta cells in the pancreas -- a breakthrough discovery that may ultimately help researchers find ways to restore or increase beta cell function in people with type 1 diabetes.
Stem Cells from Adults Could Lead to New Diabetes Treatment
Researchers are capitalizing on the memories of stem cells generated from adult cells to bring new hope to sufferers of juvenile or type 1 diabetes.
Study: Drug Improves Glycemic Control Significantly in Type 1 Diabetics on Insulin
Results portend first major advance for type 1 diabetics since insulin was discovered. New study shows that liraglutide reduces the wide swings in blood glucose numbers that characterize even well-controlled type 1 diabetes.
Experimental Cure for Type 1 Diabetes Has Almost 80-percent Success Rate
An experimental cure for Type 1 diabetes has a nearly 80 percent success rate. The results offer possible hope of curing a disease that affects 3 million Americans.
